Speaker illustration

Doctor Haotian Gu

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

First-phase ejection fraction, a measure of pre-clinical heart failure, is strongly associated with increased mortality in patients with COVID-19

Event: ESC Congress 2021 - The Digital Experience

Topic: Imaging

Session: Chronic heart failure e-posters

Thumbnail

First-phase ejection fraction predicts response to cardiac resynchronization therapy and adverse outcomes

Event: ESC Congress 2020

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Chronic Heart Failure ePosters

Thumbnail

Early systolic function is impaired in patients with heart failure and preserved ejection fraction and is a more important predictor of clinical outcomes than diastolic function

Event: EuroEcho 2019

Topic: Systolic and Diastolic Function

Session: Imaging: systolic and diastolic function

Thumbnail

First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction

Event: EuroEcho-Imaging 2018

Topic: Valvular Heart Disease

Session: Echocardiography: Valve Disease

Thumbnail

Reduced first-phase ejection fraction in severe aortic stenosis patients with preserved overall ejection fraction

Event: EuroEcho-Imaging 2017

Topic: Aortic stenosis

Session: Heart valves

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb